Studie

L-Taurine Reduces Fatigue in Decompensated Cirrhosis: RCT

Multiple authors

RANDOMIZED CONTROLLED TRIAL Tier 2 2026

Taurine supplementation reduced fatigue in patients with decompensated cirrhosis in an RCT.

StudiedesignRANDOMIZED CONTROLLED TRIAL
TierTier 2, Strong human evidence, hard endpoints or biomarkers
År2026
TidskriftHepatology Communications
Publiceradapr 24, 2026
Tillagd i NO1GEVITYaug 7, 2026

A randomiserad kontrollerad studie published in Hepatology Communications found that L-taurine supplementation reduced fatigue in patients with decompensated cirrhosis. While this is a disease-specific population, not a healthy aging population, it adds to the growing body of human RCT evidence for taurine. Taurine has gained attention in longevity research after a 2023 Science paper showed age-related decline in taurine levels and lifespan extension in mice. This RCT adds clinical evidence to the mechanistic and animal data. Fatigue is a common age-related complaint, and if taurine reduces fatigue in a severely fatigued population, it may also help in milder age-related fatigue, though this requires separate testing. The dose, sample size, and effect size were not specified in the source material.

L-taurine reduced fatigue in decompensated cirrhosis patients in a randomiserad kontrollerad studie.
Kritikernoter

Disease-specific population (cirrhosis), not healthy aging. Sample size, dose, and effect size not specified in source.

Läs källan

Citerad av

1 encyklopediartiklar refererar till denna studie.